Literature DB >> 23053979

p53 Codon 72 arginine/proline polymorphism and cancer in Sudan.

Huda A Eltahir1, Ameera A M Adam, Zeinab A Yahia, Noon F Ali, Dalia M Mursi, Ashraaf M Higazi, Nahid A Eid, Ahmed M Elhassan, Hiba S Mohammed, Muntaser E Ibrahim.   

Abstract

The aim of this report is to determine frequencies and associations of p53 codon 72 arg/pro polymorphism with different types of cancer in Sudan. p53 codon72 arg/pro polymorphism distribution and allele frequencies in 264 samples of different types of cancers were investigated using PCR. The results were compared to 235 normal controls. The results indicated significant differences in frequency and genotype association between different types of cancers. Breast carcinoma patients most prominently showed excess of homozygous arg genotype as compared to controls with an Odd ratio (OR) of 19.44, 95 %CI: 6.6-78.3, P < 0.0001. Less prominently cervical cancer showed genotype effect of 2.4 OR, 95 %CI: 1.12-5.33, P = 0.015, while esophageal cancer had an OR of 0.57, 95 %CI: 0.23-1.42, P = 0.1. In Burkitt's lymphoma, however, in contrast the homozygous arg accounted for only 6.9 %, (OR 0.18, 95 %CI: 0.02-0.89, P = 0.018). We concluded that p53 arg/pro polymorphism has different pattern of frequency in different types of cancer among Sudanese patients, indicating perhaps different etiology and biology of these tumours.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23053979     DOI: 10.1007/s11033-012-1978-0

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  14 in total

1.  p53 genotypes and haplotypes associated with risk of breast cancer.

Authors:  Nur Buyru; Julide Altinisik; Semra Demokan; Nejat Dalay
Journal:  Cancer Detect Prev       Date:  2007-06-18

Review 2.  p53, the cellular gatekeeper for growth and division.

Authors:  A J Levine
Journal:  Cell       Date:  1997-02-07       Impact factor: 41.582

3.  TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: a meta-analysis.

Authors:  De-Ke Jiang; Lei Yao; Wen-Zhang Wang; Bo Peng; Wei-Hua Ren; Xian-Mei Yang; Long Yu
Journal:  World J Gastroenterol       Date:  2011-03-07       Impact factor: 5.742

4.  Primary structure polymorphism at amino acid residue 72 of human p53.

Authors:  G J Matlashewski; S Tuck; D Pim; P Lamb; J Schneider; L V Crawford
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

5.  p53 codon 72 polymorphism does not affect the risk of cervical cancer in patients from northern Italy.

Authors:  P Tenti; N Vesentini; M Rondo Spaudo; R Zappatore; P Migliora; L Carnevali; G N Ranzani
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-04       Impact factor: 4.254

6.  p53 codon 72 polymorphism and the risk of esophageal cancer: a Korean case-control study.

Authors:  J-M Piao; H N Kim; H-R Song; S-S Kweon; J-S Choi; J-Y Yoon; I J Chung; S-H Kim; M-H Shin
Journal:  Dis Esophagus       Date:  2011-05-19       Impact factor: 3.429

Review 7.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

Review 8.  p53 polymorphisms: cancer implications.

Authors:  Catherine Whibley; Paul D P Pharoah; Monica Hollstein
Journal:  Nat Rev Cancer       Date:  2009-02       Impact factor: 60.716

9.  Contribution of retinoblastoma LOH and the p53 Arg/Pro polymorphism to cervical cancer.

Authors:  Huda A Eltahir; Ahmed M Elhassan; Muntaser E Ibrahim
Journal:  Mol Med Rep       Date:  2012-06-11       Impact factor: 2.952

10.  Nasopharyngeal cancer in Sudan: epidemiology, clinical and histological characteristics.

Authors:  Nazik E Abdullah; Ameera A M Adam; Eman H Khalifa; Lamyaa A M El Hassan; M E Ibrahim; K M Hamad; A M El Hassan
Journal:  Clin Med Insights Ear Nose Throat       Date:  2011-02-22
View more
  5 in total

1.  The preliminary study of p53 codon 72 polymorphism and risk of cervical carcinoma in Gabonese women.

Authors:  Samira Zoa Assoumou; Anicet Luc M Boumba; Angelique Ndjoyi-Mbiguino; Abdelkrim Khattabi; Moulay Mustapha Ennaji
Journal:  Med Oncol       Date:  2014-12-12       Impact factor: 3.064

2.  Epstein Barr virus: a prime candidate of breast cancer aetiology in Sudanese patients.

Authors:  Zeinab A Yahia; Ameera Am Adam; Magdeldin Elgizouli; Ayman Hussein; Mai A Masri; Mayada Kamal; Hiba S Mohamed; Kamal Alzaki; Ahmed M Elhassan; Kamal Hamad; Muntaser E Ibrahim
Journal:  Infect Agent Cancer       Date:  2014-03-07       Impact factor: 2.965

3.  Systematic Review of Genetic Factors in the Etiology of Esophageal Squamous Cell Carcinoma in African Populations.

Authors:  Hannah Simba; Helena Kuivaniemi; Vittoria Lutje; Gerard Tromp; Vikash Sewram
Journal:  Front Genet       Date:  2019-08-02       Impact factor: 4.599

Review 4.  Part I: cancer in Sudan—burden, distribution, and trends breast, gynecological, and prostate cancers.

Authors:  Amany Elamin; Muntaser E Ibrahim; Dafalla Abuidris; Kamal Eldin H Mohamed; Sulma Ibrahim Mohammed
Journal:  Cancer Med       Date:  2015-01-30       Impact factor: 4.452

5.  Lack of association between Bax promoter (-248G>A) single nucleotide polymorphism and susceptibility towards cancer: evidence from a meta-analysis.

Authors:  Sushil Kumar Sahu; Tathagata Choudhuri
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.